https://www.selleckchem.com/products/kpt-330.html
Y772_A775dup and HER2 amplification even after failures of multiple anti-HER2 therapies. It also indicated the value of capture-based next-generation sequencing to monitor and guide therapy. Pancreatic cancer is one of the most malignant tumors, and gemcitabine has been considered as the standard treatment and been widely utilized as a first-line drug for advanced pancreatic cancer, but gemcitabine-resistance always occurs after a short period of treatment. Two pancreatic cancer cell lines Panc-1 and MIA-PaCa-2 were used as the study su
Gefällt mir
Kommentar
Teilen
